Evidence map›Paper›PMID 31010931›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Circulating heparin oligosaccharides rapidly target the hippocampus in sepsis, potentially impacting cognitive functions.

Xing Zhang, Xiaorui Han, Ke Xia, Yongmei Xu, Yimu Yang, Kaori Oshima, Sarah M Haeger, Mario J Perez, Sarah A McMurtry, Joseph A Hippensteel and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Lung endothelial cytopathic tau is sufficient to impair long-term potentiation during infection.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Mechanisms of lung crosstalk with end organs: scientific session V-ReSPIRE 2025.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Observational
  11. A role for decorin in improving motor deficits after traumatic brain injury.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  12. Cerebrovascular glycocalyx damage and microcirculation impairment in patients with temporal lobe epilepsy.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  13. Review
  14. Review
  15. Using heparan sulfate octadecasaccharide (18-mer) as a multi-target agent to protect against sepsis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Analysis of 3-Analytical chemistry · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Xing ZhangDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180.
Xiaorui HanDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180.
Ke XiaDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180.
Yongmei XuDepartment of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Yimu YangDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Kaori OshimaDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Sarah M HaegerDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Mario J PerezDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Sarah A McMurtryDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Joseph A HippensteelDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.ORCID 0000-0003-4082-6993
Joshay A FordDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.
Paco S HersonDepartment of Anesthesiology, University of Colorado Denver, Aurora, CO 80045.
Jian LiuDepartment of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Eric P SchmidtDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045.ORCID 0000-0002-7360-0504
Robert J LinhardtDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180; linhar@rpi.edu.
University of Colorado Denver · USRensselaer Polytechnic Institute · USUniversity of North Carolina at Chapel Hill · USDenver Health Medical Center · USNanjing Normal University · CN

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
In vitro synthesis of recombinant heparan sulfateR01HL094463 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JIAN, PAWLINSKI, RAFAL L · 2009 to 2021
$5.2M
Endothelial glycocalyx reconstitution during sepsisR01HL125371 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LINHARDT, ROBERT J, SCHMIDT, ERIC PETER · 2014 to 2018
$3.4M
The role ofglycosaminoglycan N-sulfation in glomerular biology/pathobiologyR01DK111958 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI MCCARTHY, KEVIN JOHN · 2017 to 2021
$2.6M
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathyR01GM125095 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI HERSON, PACO S, SCHMIDT, ERIC PETER · 2017 to 2020
$1.9M
An Automated Platform for the CE-MS Analysis of GlycosaminoglycansU01CA231074 · NCI · UNIVERSITY OF GEORGIA · PI AMSTER, I JONATHAN · 2018 to 2020
$895k
NCI NIH HHS U01 CA231074NHLBI NIH HHS R01 HL094463NHLBI NIH HHS R01 HL125371NIDDK NIH HHS R01 DK111958NIGMS NIH HHS R01 GM125095NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Sepsis induces heparanase-mediated degradation of the endothelial glycocalyx, a heparan sulfate-enriched endovascular layer critical to vascular homeostasis, releasing highly sulfated domains of heparan sulfate into the circulation. These domains are oligosaccharides rich in heparin-like trisulfated disaccharide repeating units. Using a chemoenzymatic approach, an undecasaccharide containing a uniformly

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCognitionHeparan SulfateHeparinHippocampusHumansMaleMiceMice, Inbred C57BLOligosaccharidesSepsisBrain-Derived Neurotrophic FactorHeparan SulfateHeparinOligosaccharidesbraindistributionheparin oligosaccharidessepsisstable isotope labeling

Identifiers

PMID31010931
PMCPMC6511061
OpenAlexW2937182429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.